Heng Marilyn, Fourman Mitchell S, Mitrevski Aiden, Berner Emily, Lozano-Calderon Santiago A
Orthopaedic Trauma Service, Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, MA, USA.
Orthopaedic Oncology Service, Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, MA, USA.
Arthroplast Today. 2022 Oct 11;18:1-6. doi: 10.1016/j.artd.2022.08.022. eCollection 2022 Dec.
Pathologic acetabular defects can undermine the stability and osseointegration of a primary total hip arthroplasty (THA) acetabular component. Our service has used photodynamic nails (PDNs) in a modified Harrington technique to provide space-filling stability to a primary acetabular implant without impeding local osseointegration. Here we describe our experience with PDN-augmented THAs.
An institutional review board-approved retrospective analysis of all patients who underwent PDN-augmented THA in the management of severe (Harrington class II or III) acetabular defects from September 1, 2020 to May 1, 2021 with at least 6 months of follow-up was performed. The primary outcome was implant survivorship. Comparisons between preoperative and 6-week postoperative visual analogue pain scores were made using the Mann-Whitney U test.
Six patients were included in this case series, 5 with metastatic cancer and 1 with pelvic discontinuity and avascular necrosis following failed attempted acetabular fixation. The mean follow-up duration was 10.3 ± 4.3 months. The mean age was 75.5 ± 4.7 years, mean body mass index 27.3 ± 5.6, and 5 patients were female. All but 1 patient was American Society of Anesthesiologists (ASA) class III. Two patients required acetabular revisions, one for aseptic loosening and a second for a pathologic fracture secondary to disease progression. One patient passed away 90 days after the procedure. The mean visual analogue pain score significantly improved from 7.8 ± 1.6 to 2.0 ± 1.4 six weeks after surgery ( = .008).
PDN augmentation of the periacetabular bone of patients with large pelvic defects yields durable pain relief and function in vulnerable hosts. PDN should be considered a part of the reconstructive surgeon's armamentarium.
病理性髋臼缺损会破坏初次全髋关节置换术(THA)髋臼组件的稳定性和骨整合。我们的科室采用改良哈灵顿技术中的光动力钉(PDN),为初次髋臼植入物提供空间填充稳定性,同时不妨碍局部骨整合。在此,我们描述我们使用PDN增强型THA的经验。
对2020年9月1日至2021年5月1日期间接受PDN增强型THA治疗严重(哈灵顿II级或III级)髋臼缺损且随访至少6个月的所有患者进行了机构审查委员会批准的回顾性分析。主要结局是植入物存活率。术前和术后6周视觉模拟疼痛评分的比较采用Mann-Whitney U检验。
本病例系列纳入6例患者,5例患有转移性癌症,1例因髋臼固定术失败后出现骨盆连续性中断和缺血性坏死。平均随访时间为10.3±4.3个月。平均年龄为75.5±4.7岁,平均体重指数为27.3±5.6,5例为女性。除1例患者外,所有患者均为美国麻醉医师协会(ASA)III级。2例患者需要进行髋臼翻修,1例因无菌性松动,另1例因疾病进展继发病理性骨折。1例患者在手术后90天去世。术后6周,平均视觉模拟疼痛评分从7.8±1.6显著改善至2.0±1.4(P = 0.008)。
对骨盆大缺损患者的髋臼周围骨进行PDN增强可在脆弱宿主中产生持久的疼痛缓解和功能改善。PDN应被视为重建外科医生的工具之一。